A @Horizoneu.bsky.social MSCA-DN training students to advance microbiota medicine. Coordinated by @mbdlab.bsky.social at @leibniz-hki.de.https://bsky.app/profile/miccrobiotackle.bsky.socialhttps://bsky.app/profile/miccrobiotackle.bsky.social/post/3lsduh4t6tc2r🧬 Meet WP1 students! Their focus? How the microbiome impacts cachexia across cancer types. 👨‍🔬Tongkun: cross-cancer multi-omics & ML models for diagnosis 👩‍🔬Mariem: epidemiology and microbiome of cachexia in colon cancer 👩‍🔬Mia: microbiome & muscle wasting links 👩‍🔬Rahma: cytokines & microbiome links24 Jun 2025 10:15 +0000at://did:plc:ziiyncvbsfcwz5ltajfabtfa/app.bsky.feed.post/3lsduh4t6tc2rhttps://bsky.app/profile/miccrobiotackle.bsky.social/post/3lrniq5kxo42aHere we are! MiCCrobioTAckle is a @Horizoneu.bsky.social doctoral network coordinated by @Leibniz-HKI.de. Our goal is to advance research at the intersection between gut #microbiota and #cancer cachexia. Follow us for exciting research! #MSCA #DoctoralNetworks #HorizonEurope15 Jun 2025 12:46 +0000at://did:plc:ziiyncvbsfcwz5ltajfabtfa/app.bsky.feed.post/3lrniq5kxo42ahttps://bsky.app/profile/miccrobiotackle.bsky.social/post/3lslkddykp22kHappy #WorldMicrobiomeDay! Today, our last WP: From discovery to real treatments 🧬WP4 turns microbiota science into therapy for cancer cachexia. Sagnik: designs FMT-based therapies, Anna: leads oral vs. tube-FMT trial, Colleen: builds consortium-in-a-pill #FMTinAPill #GutMicrobiome #CancerCachexia27 Jun 2025 11:35 +0000at://did:plc:ziiyncvbsfcwz5ltajfabtfa/app.bsky.feed.post/3lslkddykp22khttps://bsky.app/profile/miccrobiotackle.bsky.social/post/3lsixieemo22x🔬 Validating Microbiome–Cachexia Links In MiCCrobioTAckle, we’re uncovering how microbial imbalances drive cancer cachexia (CC). Work Package 3 (WP3) dives into causality—testing how native or engineered microbes affect cachexia in experimental models. Meet the WP3 PhD researchers:26 Jun 2025 10:52 +0000at://did:plc:ziiyncvbsfcwz5ltajfabtfa/app.bsky.feed.post/3lsixieemo22xhttps://bsky.app/profile/miccrobiotackle.bsky.social/post/3lsgrdmou222q🧪 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗠𝗶𝗰𝗿𝗼𝗯𝗲𝘀 | 𝗪𝗣𝟮 In our project tackling cancer cachexia, WP2 focuses on developing next-gen microbial therapeutics restoring gut barrier function and regulate appetite. 🎓𝗠𝗲𝗲𝘁 𝘁𝗵𝗲 𝘀𝘁𝘂𝗱𝗲𝗻𝘁𝘀: 🔬 𝗔𝗱𝗮𝗺 𝗝𝗲𝗻𝗼𝗳𝗮𝗹𝘃𝗶 (DTU) – Engineering 𝘚. 𝘣𝘰𝘶𝘭𝘢𝘳𝘥𝘪𝘪 to deliver gut-targeted therapies25 Jun 2025 13:57 +0000at://did:plc:ziiyncvbsfcwz5ltajfabtfa/app.bsky.feed.post/3lsgrdmou222qhttps://bsky.app/profile/miccrobiotackle.bsky.social/post/3lsduh4t6tc2r🧬 Meet WP1 students! Their focus? How the microbiome impacts cachexia across cancer types. 👨‍🔬Tongkun: cross-cancer multi-omics & ML models for diagnosis 👩‍🔬Mariem: epidemiology and microbiome of cachexia in colon cancer 👩‍🔬Mia: microbiome & muscle wasting links 👩‍🔬Rahma: cytokines & microbiome links24 Jun 2025 10:15 +0000at://did:plc:ziiyncvbsfcwz5ltajfabtfa/app.bsky.feed.post/3lsduh4t6tc2rhttps://bsky.app/profile/miccrobiotackle.bsky.social/post/3lsb5zqy4gs2m🌍 World Microbiome Day is almost here — June 27! Microbiomes are communities of bacteria, fungi, and viruses that impact our health in huge ways. At MiCCrobioTAckle, we’re researching how the gut microbiome affects cancer cachexia — a serious condition affecting over 80% of cancer patients. 1/n23 Jun 2025 08:28 +0000at://did:plc:ziiyncvbsfcwz5ltajfabtfa/app.bsky.feed.post/3lsb5zqy4gs2mhttps://bsky.app/profile/miccrobiotackle.bsky.social/post/3lrniq5kxo42aHere we are! MiCCrobioTAckle is a @Horizoneu.bsky.social doctoral network coordinated by @Leibniz-HKI.de. Our goal is to advance research at the intersection between gut #microbiota and #cancer cachexia. Follow us for exciting research! #MSCA #DoctoralNetworks #HorizonEurope15 Jun 2025 12:46 +0000at://did:plc:ziiyncvbsfcwz5ltajfabtfa/app.bsky.feed.post/3lrniq5kxo42a